Welcome to the Helm Benefit Design, Inc. Health News Summary. These news items relate to current medication and pharmacy benefit issues. For more information about our services, and to help understand how this information and more can be applied to your company's pharmacy benefits, visit our website, or contact us
Sunday, November 7, 2010
July 8, 2010 - FDA Cautions Against Using Quinine For Leg Cramps.
The Los Angeles Times (7/8, Maugh) reported, "The Food and Drug Administration on Thursday cautioned consumers against using quinine [Qualaquin] for" nocturnal "leg cramps, warning that the drug could cause severe side effects, including death." Indeed, "studies have shown that it can reduce the incidence of cramps by one-third to one-half." However, "as many as one in every 25 users can suffer serious side effects." The FDA issued the warning due to adverse-event reporting system, according to the Wall Street Journal (7/8, Dooren). Over three and a half years, 38 reports had been submitted. In those reports, "24 instances of serious life-threatening reactions" were noted according to MedPage Today (7/8, Petrochko). "These adverse events resulted in permanent kidney impairment and hospitalization in some people, and death in two." This warning reiterates a prior warning from 2006. Nevertheless according to the FDA, most of the quinine used in the United States continues to be for the prevention or treatment of leg cramps.